Article
Novel homozygous CD46 variant with C-isoform expression affects C3b inactivation in atypical hemolytic uremic syndrome.
European journal of immunology - 1 Oct 2022
Schack Vivien R, Herlin Morten K, Pedersen Henrik, Jensen J Magnus Bernth, Faerch Mia, Bundgaard Bettina, Jensen Rasmus K, Jensen Uffe B, Christensen Rikke, Andersen Gregers R, Thiel Steffen, Höllsberg Per
Abstract excerpt
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy that may lead to organ failure. Dysregulation of the complement system can cause aHUS, and various disease-related variants in the complement regulatory protein CD46 are described. We here report a pediatric patient with aHUS carrying a hitherto unreported homozygous variant in CD46 (NM_172359.3:c.602C>T p.(Ser201Leu)). In our functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
